Antibody responses to hepatitis A virus vaccination in thai hiv-infected children with immune recovery after antiretroviral therapy

Pediatr Infect Dis J. 2011 Mar;30(3):256-9. doi: 10.1097/INF.0b013e3181f812f8.

Abstract

The prevalence of hepatitis A virus (HAV) protective antibody in 98 Thai HIV-infected children who achieved immune recovery after antiretroviral therapy was 12.2%. After a 2-dose HAV vaccination, 98.8% (85 of 86 children) seroconverted. The geometric mean titer was 520.95 mIU/mL. In a multivariate analysis, female gender, age < 12 years and higher CD4 lymphocyte count at enrollment were predicting factors for high (≥ 250 mIU/mL) HAV antibody response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anti-HIV Agents / administration & dosage*
  • Antiretroviral Therapy, Highly Active*
  • Child
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • Hepatitis A Antibodies / blood*
  • Hepatitis A Vaccines / immunology*
  • Humans
  • Male
  • Thailand

Substances

  • Anti-HIV Agents
  • Hepatitis A Antibodies
  • Hepatitis A Vaccines